PMYZX
Price
$46.00
Change
-$0.15 (-0.33%)
Updated
Aug 15 closing price
Net Assets
5.77B
VTSAX
Price
$154.04
Change
-$0.41 (-0.27%)
Updated
Aug 15 closing price
Net Assets
1.91T
Interact to see
Advertisement

PMYZX vs VTSAX

Header iconPMYZX vs VTSAX Comparison
Open Charts PMYZX vs VTSAXBanner chart's image
Putnam Core Equity Fund R
Price$46.00
Change-$0.15 (-0.33%)
VolumeN/A
Net Assets5.77B
Vanguard Total Stock Mkt Idx Adm
Price$154.04
Change-$0.41 (-0.27%)
VolumeN/A
Net Assets1.91T
PMYZX vs VTSAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PMYZX vs. VTSAX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMYZX is a Buy and VTSAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.91T vs. PMYZX (5.78B). VTSAX pays higher dividends than PMYZX: VTSAX (1.18) vs PMYZX (0.22). PMYZX was incepted earlier than VTSAX: PMYZX (15 years) vs VTSAX (25 years). PMYZX (1.23) is less costly to investors than VTSAX (0.04). PMYZX is a more actively managed with annual turnover of: 11.00 vs. VTSAX (2.00). PMYZX has a lower initial minimum investment than VTSAX: PMYZX (0) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 16.53 vs. PMYZX (12.35). VTSAX return over 5 years is better than : 86.35 vs. PMYZX (77.67).
PMYZXVTSAXPMYZX / VTSAX
Total Expense Ratio1.230.043,075%
Annual Report Gross Expense Ratio1.230.043,075%
Fund Existence15 years25 years-
Gain YTD8.9739.56694%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.78B1.91T0%
Annual Yield % from dividends0.221.1819%
Returns for 1 year12.3516.5375%
Returns for 3 years43.1547.2191%
Returns for 5 years77.6786.3590%
Returns for 10 years166.45203.9882%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTGN3.310.36
+12.01%
VistaGen Therapeutics
RXRX5.770.13
+2.30%
Recursion Pharmaceuticals
FTV48.160.36
+0.75%
Fortive Corp
DSS0.83N/A
+0.39%
DSS
CBNK32.68-0.32
-0.97%
Capital Bancorp